Moderna, Inc. — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-05-12

Reporting Person: Kim Lorence H. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-12	Common Stock	M	11643	$12.21	Acquired	1234153	Direct
2020-05-12	Common Stock	M	229357	$10.90	Acquired	1463510	Direct
2020-05-12	Common Stock	S	35182	$62.56	Disposed	1428328	Direct
2020-05-12	Common Stock	S	31948	$63.57	Disposed	1396380	Direct
2020-05-12	Common Stock	S	104544	$64.67	Disposed	1291836	Direct
2020-05-12	Common Stock	S	61412	$65.47	Disposed	1230424	Direct
2020-05-12	Common Stock	S	5677	$66.43	Disposed	1224747	Direct
2020-05-12	Common Stock	S	2237	$67.32	Disposed	1222510	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-12	Stock Option (Right to Buy)	$10.90	M	229357	Disposed	2026-02-23	Common Stock (229357)	Direct
2020-05-12	Stock Option (Right to Buy)	$12.21	M	11643	Disposed	2027-02-23	Common Stock (11643)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.04 to $63.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.07 to $64.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.09 to $65.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.10 to $66.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.12 to $66.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.16 to $67.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: This option is fully vested and exercisable.

F9: 25% of this option vested and became exercisable on February 22, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.